Metabolon
PrivateLast Round
Debt
May 16, 2024
Total Funding Raised
$172.29M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Metabolon is a biotechnology company that develops proprietary analytical methods and software for biomarker discovery using metabolomics to provide biological insights for life sciences research and drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Metabolon Comparables
Compare Metabolon with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sapient | 80% | |
| Metware Biotechnology | 79% | |
| Human Metabolome Technologies Inc. | 79% | |
Metabolon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | May 16, 2024 | ||||
| VC Round | Jan 24, 2023 | ||||
| VC Round | Sep 23, 2020 | ||||
| Grant | Apr 8, 2020 | ||||
| Debt | Oct 11, 2018 | ||||
Series E | Aug 17, 2018 |
Key People
Founding team and executive leadership
Metabolon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Trelys Funds | Series B, Series A |
| Innovatus Capital Partners | Debt |
| Fulcrum Financial Services | Series D, Series E, Series C |
| Perceptive Advisors | VC Round |
| EW Healthcare Partners | VC Round, Secondary |
| Fletcher Spaght | Series D, Series C |
| Fletcher Spaght Ventures | Series D, Series E, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 17, 2026
Collaborating with The Michael J. Fox Foundation on Parkinson's disease research.
- Jan 14, 2026
Celia Reyes appointed as the new Vice President of Human Resources.
Metabolon Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Metabolon's valuation, stock price, and market status.